 CAMBRIDGE, Mass., Sept. 01, 2022 GLOBE NEWSWIRE -- Vigil Neuroscience, Inc. Nasdaq: VIGL, a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that members of the management team will participate in a fireside chat at the 2022 Morgan Stanley Global Healthcare Conference on Monday, September 12, 2022, at 4:50 p.m. ET. 